What's happening?

60 Minutes: 48x35

Breakthrough Status, Collateral Damage

Scott Pelley follows patients in a Duke clinical trial of a new cancer therapy that the FDA has granted breakthrough status; and, Bill Whitaker reports on how the U.S. fight against Chinese espionage has ensnared innocent Americans.

May. 15, 2016

Leave a comment

Name *
Add a display name
Email *
Your email address will not be published